Post-earnings recap
Reported
Wed, Aug 14, 2024
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
CorMedix Inc. reported a narrower loss per share than expected, which contributed to a significant stock price increase of 30.16%. The lack of revenue figures and management commentary leaves some uncertainty about the company's overall performance and future direction. Investors may be reacting positively to the EPS surprise, indicating optimism about the company's financial health.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.25 | N/A | +3.85% |
| Revenue | N/A | N/A | — |
No transcript is on record, and the analysis is based on numerical results only.